The molecular signature of clinical localised prostate cancer
By measuring mRNA expression and miRNA expression in microdissected prostate tumours from patients undergoing radical prostatectomy, a molecular classifier that outperforms traditional prognostic markers for disease outcome is generated - to distinguish clinically important from unimportant prostate cancer.
Contact:
Martin Mørck Mortensen MD, martinmortensen@hotmail.com